Cite
Brady JL, Harrison LC, Goodman DJ, et al. Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model. Clin Transl Immunology. 2014;3(12):e29doi: 10.1038/cti.2014.28.
Brady, J. L., Harrison, L. C., Goodman, D. J., Cowan, P. J., Hawthorne, W. J., O'Connell, P. J., Sutherland, R. M., & Lew, A. M. (2014). Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model. Clinical & translational immunology, 3(12), e29. https://doi.org/10.1038/cti.2014.28
Brady, Jamie L, et al. "Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model." Clinical & translational immunology vol. 3,12 (2014): e29. doi: https://doi.org/10.1038/cti.2014.28
Brady JL, Harrison LC, Goodman DJ, Cowan PJ, Hawthorne WJ, O'Connell PJ, Sutherland RM, Lew AM. Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model. Clin Transl Immunology. 2014 Dec 19;3(12):e29. doi: 10.1038/cti.2014.28. eCollection 2014 Dec. PMID: 25587392; PMCID: PMC4282178.
Copy
Download .nbib